Bioextrax (BIOEX.ST) Stock Analysis & AI Equity Report

Waste Management SEK Explore free reports

Bioextrax (BIOEX.ST) overview

Bioextrax (BIOEX.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Bioextrax reported revenue of SEK 0.8m and operating profit of SEK -18.4m; the year-end share price was 2.80 SEK and market capitalisation was SEK 111m. Bioextrax is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Bioextrax's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueSEK 21.2mFY 2025
Share price2.80 SEKFY 2025 year end
RevenueSEK 0.8mFY 2025
Operating profitSEK -18.4mFY 2025
Net earningsSEK -17.7mFY 2025
Market capitalisationSEK 111mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Bioextrax

Bioextrax AB is a Swedish biotechnology company that develops and licenses patented, chemical-free processes for producing biobased materials. Its main activities include PHA-based bioplastics and the upcycling of poultry feather waste into protein hydrolysates and keratin microfibres. The company works with partners to commercialise its technologies across industrial applications.

Generate the Bioextrax report

Bioextrax is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Bioextrax and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Bioextrax

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.